Caris Life Sciences, Inc. (CAI)
Caris Life Sciences will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Caris Life Sciences Revenue
Caris Life Sciences had revenue of $452.50M in the twelve months ending March 31, 2025. In the year 2024, Caris Life Sciences had annual revenue of $412.26M with 34.67% growth.
Revenue (ttm)
$452.50M
Revenue Growth
+34.67%
P/S Ratio
n/a
Revenue / Employee
$255,793
Employees
1,769
Market Cap
n/a
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 412.26M | 106.13M | 34.67% |
| Dec 31, 2023 | 306.13M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCAI News
- 5 days ago - Caris Life Sciences Files Registration Statement for Proposed Initial Public Offering - PRNewswire
- 5 days ago - Caris Life Sciences discloses rise in revenue in US IPO filing - Reuters
- 5 days ago - Oncology precision medicine platform Caris Life Sciences files for an estimated $300 million IPO - Renaissance Capital
- 5 days ago - Caris Life Sciences IPO Registration Document (S-1) - SEC